Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001144204-19-002088

Options or other derivatives

  • Chief Financial Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
POSNER BRIAN M Chief Financial Officer 2019-01-17 Grant or award · Stock option (right to buy) +30,000 30,000 D
Loading xslF345X03/tv511257_4.xml…